Morningstar

Vanguard Health Care Adm VGHAX

Morningstar Medalist Rating
Medalist Rating as of | See Vanguard Investment Hub
  • NAV / 1-Day Return 94.42  /  +0.11 %
  • Total Assets 48.7 Bil
  • Adj. Expense Ratio
    0.300%
  • Expense Ratio 0.300%
  • Distribution Fee Level Low
  • Share Class Type Institutional
  • Category Health
  • Investment Style Large Growth
  • Min. Initial Investment 50,000
  • Status Open
  • TTM Yield 0.79%
  • Turnover 16%

USD | NAV as of Oct 04, 2024 | 1-Day Return as of Oct 04, 2024, 10:29 PM GMT+0

Morningstar’s Analysis VGHAX

Will VGHAX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

  • Process Pillar

    The Process Pillar is our assessment of how sensible, clearly defined, and repeatable VGHAX’s performance objective and investment process is for both security selection and portfolio construction.

  • People Pillar

    The People Pillar is our evaluation of the VGHAX management team’s experience and ability. We find that high-quality management teams deliver superior performance relative to their benchmarks and/or peers.

  • Parent Pillar

    The Parent Pillar is our rating of VGHAX’s parent organization’s priorities and whether they’re in line with investors’ interests.

This strategy’s future looks bright.

Analyst Andrew Redden

Andrew Redden

Analyst

Summary

Vanguard Health Care's well-executed succession plan positions this strategy for continued success.

by Andrew Redden
Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings VGHAX

More VGHAX Holdings
  • Current Portfolio Date
  • Equity Holdings —
  • Bond Holdings —
  • Other Holdings —
  • % Assets in Top 10 Holdings 43.9
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Eli Lilly and Co

9.63 4.6 Bil
Healthcare

UnitedHealth Group Inc

6.80 3.3 Bil
Healthcare

AstraZeneca PLC

5.63 2.7 Bil
Healthcare

Merck & Co Inc

4.59 2.2 Bil
Healthcare

Novartis AG Registered Shares

3.53 1.7 Bil
Healthcare

Novo Nordisk A/S Class B

3.32 1.6 Bil
Healthcare

Daiichi Sankyo Co Ltd

2.78 1.3 Bil
Healthcare

Danaher Corp

2.62 1.3 Bil
Healthcare

Alnylam Pharmaceuticals Inc

2.55 1.2 Bil
Healthcare

Thermo Fisher Scientific Inc

2.44 1.2 Bil
Healthcare

Sponsor Center